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Rosalba Lombardi,2 Stefano Nardeli,3 Maria Serena Beato,3 Katia Capello,4 Giuseppe Bertoni5
Small ruminant lentivirus infections in goats affect both production and animal welfare. This represents a threat 
to the qualitative and quantitative growth of goat farming, recently observed in mountainous regions such as the 
Autonomous Province of Bolzano – South Tyrol (Italy). To monitor and eradicate the caprine arthritis encephalitis 
virus in this goat population, a compulsory eradication campaign was launched, based on a strict census of small 
ruminants and yearly serological testing of all animals, followed by the consequent culling of seropositive indi-
viduals. The campaign succeeded in completely eliminating cases of clinical disease in goats, while drastically 
reducing the seroprevalence at the herd as well as individual animal level. The serological outcome of the intro-
duced control measures was determined using commercially available ELISA kits, demonstrating their suitability 
for use in this type of campaign, aimed at reducing seroprevalence as well as clinical manifestations of these 
infections. However, this clear success is diminished by the failure to achieve a complete eradication of these 
viruses. The reasons leading to the observed tailing phenomenon and the occurrence of new infections in already 
sanitised flocks are discussed and implementation of further measures are proposed.
Introduction
Caprine arthritis encephalitis virus (CAEV) and Maedi visna 
virus (MVV) were considered as species-specific patho-
gens of goats and sheep, respectively. Nowadays they are 
referred to as small ruminant lentiviruses (SRLV) and are 
considered to represent a genetic continuum, whose prin-
cipal representatives, that is, SRLV A (MVV), B (CAEV) and 
C (a particular genotype detected in Norway), were shown 
to cross the species barrier between goats and sheep.1–5 
Five SRLV genotypes (A–E) have been described so far, 
with A, B and E further subdivided in subtypes A1–A15, 
B1–B3 and E1–E2.4 6 As an exception, genotype E appears 
to be goat-specific.7 8 Noteworthy are the findings of several 
authors reporting genomic sequences from sheep with 
higher identities to CAEV than to MVV,9–11 indicating a 
possible common ancestral genotype. These viruses are 
widespread worldwide with the exception of New Zealand 
and Australia, which are considered free of SRLV A, and 
Iceland, which eradicated SRLV after a devastating epizo-
otic outbreak originating from the import of SRLV-infected 
karakul sheep in the early 1930s.12–20 Genotype B, and in 
particular the B1 subtype, is considered the most virulent 
genotype for goats, whereas in sheep genotype A is the 
principal cause of clinical manifestations.2 6 
SRLVs are known to be the cause of a chronic multi-
systemic inflammatory disease characterised by a long 
incubation period and a lifelong persistent infection.21 
Infections due to SRLV are associated with a progressive 
degenerative disease that involves, at different stages, 
the joints and mammary glands, causing progressive 
chronic arthritis and non-suppurative indurative mas-
titis, along with other pathological manifestations, af-
fecting both the respiratory  system and CNS.6 Clinical 
signs are apparent in less than 30 per cent of infected 
goats and sheep, pointing to the importance of host ge-
netic factors. Nonetheless, all seropositive animals rep-
resent a potential source of infection.22–26
The main routes of viral transmission are ingestion 
of colostrum and milk from infected animals and hori-
zontal transmission via respiratory secretions between 
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individuals.15 27–29 Horizontal transmission, however, 
is considered more important in sheep than goats.30–32 
Transmission to human beings is not considered a po-
tential threat because of the absence of functional re-
ceptors at the surface of human cells33; further studies 
should focus on the possibilities that recombination 
and mutation of the virus could lead to the generation 
of a potentially zoonotic virus.
Caprine arthritis encephalitis has a negative impact 
on several performance parameters, leading to econom-
ic losses.34–36 Clinical signs in SRLV-infected animals in-
clude a decrease in milk productivity and milk quality, 
loss of weight, and premature death; furthermore, ani-
mals at advanced stages of the disease present a signif-
icantly reduced bodyweight at slaughter, and therefore 
may not be suitable for consumption.15 37 38 Along with 
poor animal welfare and environmental protection,15 
these economic factors have contributed to the grow-
ing demand for control and eradication programmes 
to be undertaken by countries around the world.6 39 40 
The most commonly used prevention and eradication 
strategies are the testing and removal of serologically 
positive animals, often combined with the immediate 
separation of lambs and kids of seropositive mothers 
at birth for rearing on CAEV-negative or bovine colos-
trum, as well as the separation of seropositive from se-
ronegative flocks and the strict control of live animal 
trade.15 41 42 The success of such programmes depends 
on the reliability of the adopted diagnostic procedures, 
primarily based on the detection of specific antibodies 
in infected animals. Seroconversions can be detected a 
few weeks after infection, although some animals only 
seroconvert several months after infection. Infected an-
imals, transiently or permanently seronegative, are also 
known to occur.43–45
Serology is the most convenient technique to diagnose 
SRLV infections, even though other laboratory methods 
for the detection of antibodies or the virus genome se-
quences are available.39 40 43 44 46
The Autonomous Province of Bolzano – South Ty-
rol (Italy) is the northernmost province of Italy and is 
located on the border with Switzerland and Austria. 
It is geographically and morphologically marked by a 
pronounced subalpine to alpine terrain. The character-
istics of the territory determine the conformation and 
size of the typical mountain farms, with an average of 
11 goats per herd. South Tyrol’s animal husbandry is 
characterised by a multispecies farming system, where 
goats, sheep and cattle can be found in the same barn. 
In 2015, the total number of goats in the Province of 
Bolzano amount to 23 806 animals held on 2207 farms; 
30 per cent of these are mixed goat–sheep breeding sys-
tem farms. The increasing number of goats is based on 
the recent growing demand for caprine dairy products, 
both by breeders and consumers. On the other hand, 
the ovine population consists of 42 187 animals. From 
the economical as well as emotional point of view, goat 
breeding plays an important role in the agricultural 
landscape in the Province of Bolzano. The adverse im-
pact of SRLV infections on goat milk and cheese produc-
tion, as well as the negative effect of these infections on 
the successful breeding of the Passirian goat, an endan-
gered local breed, has driven the local authorities to im-
plement an eradication programme targeting CAEV in 
goats. Preliminary serological surveys and a pilot pro-
ject launched between December 2003 and May 2004 
showed that the preconditions for a successful eradica-
tion campaign, that is, a relatively low seroprevalence 
and the motivation of the participating goat breeders, 
were fulfilled.28 47 48 The compulsory CAEV eradication 
programme was therefore started in November 2007. In 
this publication, we describe the results obtained so far 
and discuss the problems encountered during the im-
plementation phase and their impact on the future of 
this eradication plan.
Materials and methods
Eradication programme
The compulsory CAEV eradication programme, which 
started in November 2007 and is still ongoing, is subdivided 
in yearly recurrent serological testing campaigns lasting 
from November 1 to April 30 of the following year, with 
the culling of all infected animals. Based on the pilot study 
conducted in 2003–2004, all goat herds within the terri-
tory of the Autonomous Province of Bolzano (on average 
2086 farms/serological testing campaign) were included 
in the eradication programme. During each campaign, 
both female and male goats older than six months of age 
(on average 19,487 animals/campaign) were tested for 
anti-CAEV antibodies. All goats that reacted positively or 
inconclusively to the analysis were considered CAEV-in-
fected. Furthermore, non-tested kids (younger than six 
months of age) born from seropositive does, which had 
been fed colostrum from the infected mother and/or had 
been in close contact with her, were considered infected 
as well. All herds with at least one infected animal were 
considered infected. In all multispecies farming systems 
with at least one positive goat, all sheep were analysed 
for anti-CAEV antibodies as well, and seropositive sheep 
were culled. Furthermore, whenever more than 30  per 
cent of a herd had tested positive, all animals were elim-
inated. The precautionary actions, imposed by the decree 
of the veterinary authorities (Decree of the Veterinary 
Service n. 35162449), were as follows: all positive goats 
were subjected to precautionary confiscation (they were 
forbidden from auctions, market-places and grazing 
lands), had to be kept separated from all other animals of 
the herd and had to be culled within 60 days from the labo-
ratory result.
Herds and animals
All goat herds within the territory of the Autonomous 
Province of Bolzano (on average 2086 farms/serolog-
ical testing campaign) were included in the eradication 
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programme. The characteristics of each herd are 
recorded in the National and Provincial Small Rumi-
nant Database; identification of small ruminants in the 
Autonomous Province of Bolzano is implemented in 
accordance with regulation 21/2004/CE. Since 2013, 
the identification of goats has been carried out exclu-
sively by the use of electronic devices, such as ruminal 
bolus and electronic ear tags.
Serological investigation
Blood samples were drawn from the jugular vein using 
vacuum blood collection tubes with a clotting acti-
vator manufactured by Vacutest Kima (Arzergrande, 
Italy) and centrifuged for 3 minutes at 1646 g to obtain 
the serum. Serological analyses were performed by 
the serological laboratory of the Institute for Animal 
Disease Control—Istituto Zooprofilattico Sperimentale 
delle Venezie—in Bolzano. Serum samples were tested 
from November 1, 2007 to April 30, 2011 using a test 
kit from Pourquier (ELISA Maedi-Visna/CAEV Serum 
Verification, V.P032/01, Institute Pourquier, Montpel-
lier,  France) with a reported specificity (Sp)≥99.8  per 
cent and a sensitivity (Se)=97.9  per cent, and from 
November 1  2012 onwards, with an antibody test kit 
from IDEXX (MVV/CAEV p28 Ab Screening Test, IDEXX, 
France) (Sp≥99.8 per cent and Se=97.9 per cent). Both 
ELISA kits use the p28 recombinant viral capsid protein 
as the antigen. Tests were performed according to manu-
facturers’ instructions. Each year, the seroprevalence 
was calculated using a 95 per cent CI. To evaluate the 
significance of trend in seroprevalence across different 
years, the Cochran-Armitage test was applied.
Results
From November 1,  2007 to April 30,  2015, a total 
number of 155  894 goat blood samples were analysed 
for SRLV antibody. The seroprevalence decreased from 
13.9  per  cent (95  per  cent CI 13.4 to 14.4  per cent) in 
2007–2008 to 0.3 per cent (95 per cent CI 0.2 to 0.3 per 
cent) in 2014–2015 (Table  1). This trend in seropreva-
lence is statistically significant (P<0.001). A similar trend 
could also be determined for the herd prevalence. The 
observed herd prevalence in 2007–2008 was 32 per cent 
(95 per cent CI 29.9 to 34.1 per cent) and decreased over 
the coming years to 1.5  per  cent (95  per cent CI 1.3 to 
1.7 per cent) in 2014–2015 (Table 2).
Discussion
The drastic reduction in herd and individual seroprev-
alence during the period 2007–2015 indicates that 
the implemented eradication programme was highly 
successful. The statistical trend in prevalence was 
highly favourable during the first years of the eradica-
tion programme (from 13.9 to 1.0 per cent in the first 
four serological testing campaigns). In contrast, in 
the last years of the programme, we observed a tailing 
phenomenon (from 0.7 to 0.3per cent in the second four 
serological testing campaigns) with the occurrence of 
new positive cases (Table 1).
This phenomenon is inherent to SRLV eradication 
programmes and relates to the complex biology of these 
viruses.2 50 Genetic diversity, along with an absence of 
universal protocols able to detect all genotypes and 
subtypes of the virus, represents an important issue 
in testing and diagnosing SRLV-infected animals.39 44 51 
The ELISA used in this work has a high Sp and Se. The 
Office International Des Epizooties World Organisation 
for Animal Health provides information on the validity 
of ELISA with respect to other assays: it states that sev-
eral indirect ELISA protocols have shown higher Sp and 
Se against a standard comparison (Western blot or ra-
dioimmunoprecipitation).52–54 Before the establishment 
of the eradication programme, the high prevalence of 
CAEV in South Tyrol and the infection risks were par-
tially related to the transhumance practices occurring 
in the summertime, during which time sheep and goats 
from different herds with unknown CAEV sanitary sta-
tus were moved to grazing areas situated in the moun-
tains. With the implementation of the programme, sev-
eral control practices were introduced, as suggested 
in the final report of the first consensus conference on 
SRLV.15 As required by the eradication plan, nowadays 
only herds with the same sanitary status are allowed 
to be grazed on common alpine pastures. The trade of 
live animals is controlled by the veterinary authorities, 
even though occasional illegal trading has occurred, 
leading to the reinfection of these herds. Cross-species 
TABLE 1: Seroprevalence of small ruminant lentiviruses infections in 
goats subdivided in prevention campaigns 
Serological testing 
campaigns Tested goats Positive goats Seroprevalence (%) 95% CI
2007–2008 18,475 2576 13.9 13.4 to 14.4
2008–2009 17,016 657 3.9 3.6 to 4.2
2009–2010 18,163 329 1.8 1.6 to 2.0
2010–2011 19,078 196 1.0 0.9 to 1.2
2011–2012 19,665 134 0.7 0.6 to 0.8
2012–2013 19,315 96 0.5 0.4 to 0.6
2013–2014 22,756 105 0.5 0.4 to 0.6
2014–2015 21,417 65 0.3 0.2 to 0.4
There is a statistically significant trend in the progress of seroprevalence found in the 8-year 
period (P<0.001).
TABLE 2: Prevalence of positive goats herds in the Autonomous Province 
of Bolzano subdivided in prevention campaigns 
Serological testing 
campaigns Tested herds Positive herds Prevalence (%) 95% CI
2007–2008 1927 617 32.0 29.9 to 34.1
2008–2009 1975 443 22.4 20.6 to 24.3
2009–2010 2001 170 8.5 7.31 to 9.8
2010–2011 2086 119 5.7 4.7 to 6.7
2011–2012 2325 88 3.8 3.0 to 4.6
2012–2013 2039 56 2.7 2.1 to 3.6
2013–2014 2207 39 1.8 1.6 to 2.0
2014–2015 2128 32 1.5 1.3 to 1.7
There is a statistically significant trend in the progress of prevalence (P<0.001).
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transmission between sheep and goats may be particu-
larly relevant in the context of the multispecies farm-
ing55–57; in South Tyrol, we are actively monitoring such 
occurrences. In the context of analysing the occurrence 
of few remaining seropositive animals in our province, 
it is important to emphasise the fact that the Autono-
mous Province of Bolzano implemented a programme 
focused exclusively on goats. Except for promiscuous 
herds, sheep were not included in the eradication effort 
and may well function as SRLV reservoir. We are plan-
ning different studies to assess the risk of the typical 
multispecies breeding system in our region, with the 
goal of adapting the eradication programme. Further-
more, the presence of wild ruminants in our grazing ar-
eas could impact a herd’s sanitary status, as transmis-
sion of SRLV between goats, sheep and wild ruminants 
has been described.5 58–60
In spite of the fact that trading individuals between 
herds and animal importation is strictly limited to herds 
with the same sanitary status, we identified the trade 
of animals as one of the two principal causes of rein-
fection. The second most crucial factor was the poten-
tial presence of false-negative animals in the sanitised 
herds, resulting from the use of a single serological as-
say (A. Tavella, unpublished observations).51 It is com-
mon for farmers in South Tyrol to use the same buck 
in several herds; even though this should only occur 
between farms with the same sanitary status, unfortu-
nately it sometimes occurs between seropositive and 
seronegative herds. The use of the same breeding buck 
in herds with different sanitary status may be an impor-
tant risk factor undermining the eradication effort.56 61
Finally, the goal of this mandatory programme was 
to determine and reduce the seroprevalence of CAEV in 
the goat population of South Tyrol, thereby eliminating 
the CAEV-induced clinical manifestations and poten-
tially eradicating the virus. The first two aims were suc-
cessfully achieved and CAEV-induced clinical disease 
in goats is no longer observed in the Autonomous Prov-
ince of Bolzano – South Tyrol. This demonstrates that 
the use of commercially available ELISA kits is suitable 
and sufficient for the assessment of CAEV control pro-
grammes aimed at reducing seroprevalence as well as 
clinical manifestations of this virus. However, the emer-
gence of new infectious cases or of singleton reactors in 
the last years of the eradication programme indicates 
that the complete eradication of SRLV from a popula-
tion cannot be easily achieved. In order to overcome 
this problem, the study and development of additional 
diagnostic tools are required.
As a consequence of these findings, we are planning 
a second phase in the eradication programme. We will 
characterise the genomic and antigenic characteristics 
of the circulating SRLV involved in reinfections, conse-
quently adapting the serological tools used in the pro-
gramme. The absence of clinical arthritis in our goats, 
strongly suggests that, in analogy to the Swiss situation, 
the virulent genotype B SRLV was almost completely 
eradicated in South Tyrol.50 The monitoring of this par-
ticular genotype will be increased by applying highly 
sensitive tests and by isolating and molecularly char-
acterising viruses from seropositive animals selectively 
slaughtered for this purpose.
In view of the important financial and human re-
source investment in such a compulsory eradication 
programme, it is extremely important to increase the 
efforts in this final difficult phase of the programme to 
prevent the reinfection of goat flocks and the spread of 
SRLV infections within our territory.
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